Senate passes bill amending drug patent laws
The Senate passed the Greater Access to Affordable Pharmaceuticals Act (section 812) on July 31, 2002, approving amendments to patent laws to make generic drug options more available to US consumers. Currently manufacturers of brand name drugs are allowed to receive an automatic 30-month stay of gen...
Gespeichert in:
| Veröffentlicht in: | Intellectual property & technology law journal 2002-11, Vol.14 (11), p.20 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 11 |
| container_start_page | 20 |
| container_title | Intellectual property & technology law journal |
| container_volume | 14 |
| creator | Tantono, Welly Selby, Sharon Bagner, Jessica Sonu, Christine |
| description | The Senate passed the Greater Access to Affordable Pharmaceuticals Act (section 812) on July 31, 2002, approving amendments to patent laws to make generic drug options more available to US consumers. Currently manufacturers of brand name drugs are allowed to receive an automatic 30-month stay of generic drug approval while litigation concerning infringement of the patent is pending. The Greater Access to Affordable Pharmaceuticals Act would limit such extensions, allowing drug manufacturers just one 30-month stay. |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_227156226</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A94820030</galeid><sourcerecordid>A94820030</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1626-4e5e6cddf29acb6a697a996aaba704a4659e83f7d10c8a504394651f7e514c123</originalsourceid><addsrcrecordid>eNptzctqwzAQBVAvWmia9h9MV13EoJdlaxlCH4FAFn1szVgeCQdZTi2Z9vMraKEphFkM3HuYucgWtOSi4JLWV9l1CAdCqJSMLLLVC3qImB8hBAx52zuXw4C-673Nu2m2qYnoY-7gM9xklwZcwNvfvczeHh9eN8_Fbv-03ax3haWSyUJgiVJ3nWEKdCtBqgqUkgAtVESAkKXCmpuqo0TXUBLBVcqoqbCkQlPGl9ndz93jNH7MGGJzGOfJp5cNYxUtJWPyD1lw2PTejHECPfRBN2slakYIJwmtziCLHidwo0fTp_iUF2d4mg6HXp_z9_98IhG_ooU5hGa7fz-h3_zDc9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227156226</pqid></control><display><type>article</type><title>Senate passes bill amending drug patent laws</title><source>Business Source Complete</source><creator>Tantono, Welly ; Selby, Sharon ; Bagner, Jessica ; Sonu, Christine</creator><creatorcontrib>Tantono, Welly ; Selby, Sharon ; Bagner, Jessica ; Sonu, Christine</creatorcontrib><description>The Senate passed the Greater Access to Affordable Pharmaceuticals Act (section 812) on July 31, 2002, approving amendments to patent laws to make generic drug options more available to US consumers. Currently manufacturers of brand name drugs are allowed to receive an automatic 30-month stay of generic drug approval while litigation concerning infringement of the patent is pending. The Greater Access to Affordable Pharmaceuticals Act would limit such extensions, allowing drug manufacturers just one 30-month stay.</description><identifier>ISSN: 1534-3618</identifier><language>eng</language><publisher>Clifton: Aspen Publishers, Inc</publisher><subject>Drugs ; FDA approval ; Federal legislation ; Generic drugs ; Intellectual property ; Interpretation and construction ; Litigation ; Patent law ; Pharmaceutical industry ; Prescription drug plans</subject><ispartof>Intellectual property & technology law journal, 2002-11, Vol.14 (11), p.20</ispartof><rights>COPYRIGHT 2002 Aspen Publishers, Inc.</rights><rights>Copyright Aspen Publishers, Inc. Nov 2002</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Tantono, Welly</creatorcontrib><creatorcontrib>Selby, Sharon</creatorcontrib><creatorcontrib>Bagner, Jessica</creatorcontrib><creatorcontrib>Sonu, Christine</creatorcontrib><title>Senate passes bill amending drug patent laws</title><title>Intellectual property & technology law journal</title><description>The Senate passed the Greater Access to Affordable Pharmaceuticals Act (section 812) on July 31, 2002, approving amendments to patent laws to make generic drug options more available to US consumers. Currently manufacturers of brand name drugs are allowed to receive an automatic 30-month stay of generic drug approval while litigation concerning infringement of the patent is pending. The Greater Access to Affordable Pharmaceuticals Act would limit such extensions, allowing drug manufacturers just one 30-month stay.</description><subject>Drugs</subject><subject>FDA approval</subject><subject>Federal legislation</subject><subject>Generic drugs</subject><subject>Intellectual property</subject><subject>Interpretation and construction</subject><subject>Litigation</subject><subject>Patent law</subject><subject>Pharmaceutical industry</subject><subject>Prescription drug plans</subject><issn>1534-3618</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNptzctqwzAQBVAvWmia9h9MV13EoJdlaxlCH4FAFn1szVgeCQdZTi2Z9vMraKEphFkM3HuYucgWtOSi4JLWV9l1CAdCqJSMLLLVC3qImB8hBAx52zuXw4C-673Nu2m2qYnoY-7gM9xklwZcwNvfvczeHh9eN8_Fbv-03ax3haWSyUJgiVJ3nWEKdCtBqgqUkgAtVESAkKXCmpuqo0TXUBLBVcqoqbCkQlPGl9ndz93jNH7MGGJzGOfJp5cNYxUtJWPyD1lw2PTejHECPfRBN2slakYIJwmtziCLHidwo0fTp_iUF2d4mg6HXp_z9_98IhG_ooU5hGa7fz-h3_zDc9A</recordid><startdate>20021101</startdate><enddate>20021101</enddate><creator>Tantono, Welly</creator><creator>Selby, Sharon</creator><creator>Bagner, Jessica</creator><creator>Sonu, Christine</creator><general>Aspen Publishers, Inc</general><scope>IOV</scope><scope>ILT</scope><scope>7WY</scope><scope>7WZ</scope><scope>7XB</scope><scope>8FE</scope><scope>8FG</scope><scope>ABJCF</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>F~G</scope><scope>HCIFZ</scope><scope>K6~</scope><scope>KB.</scope><scope>L6V</scope><scope>M0C</scope><scope>M7S</scope><scope>P5Z</scope><scope>P62</scope><scope>PDBOC</scope><scope>PQBIZ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>Q9U</scope><scope>S0X</scope></search><sort><creationdate>20021101</creationdate><title>Senate passes bill amending drug patent laws</title><author>Tantono, Welly ; Selby, Sharon ; Bagner, Jessica ; Sonu, Christine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1626-4e5e6cddf29acb6a697a996aaba704a4659e83f7d10c8a504394651f7e514c123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Drugs</topic><topic>FDA approval</topic><topic>Federal legislation</topic><topic>Generic drugs</topic><topic>Intellectual property</topic><topic>Interpretation and construction</topic><topic>Litigation</topic><topic>Patent law</topic><topic>Pharmaceutical industry</topic><topic>Prescription drug plans</topic><toplevel>online_resources</toplevel><creatorcontrib>Tantono, Welly</creatorcontrib><creatorcontrib>Selby, Sharon</creatorcontrib><creatorcontrib>Bagner, Jessica</creatorcontrib><creatorcontrib>Sonu, Christine</creatorcontrib><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale OneFile: LegalTrac</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection</collection><collection>Materials Science Database</collection><collection>ProQuest Engineering Collection</collection><collection>ABI/INFORM Global</collection><collection>Engineering Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Materials Science Collection</collection><collection>ProQuest One Business</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><jtitle>Intellectual property & technology law journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tantono, Welly</au><au>Selby, Sharon</au><au>Bagner, Jessica</au><au>Sonu, Christine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Senate passes bill amending drug patent laws</atitle><jtitle>Intellectual property & technology law journal</jtitle><date>2002-11-01</date><risdate>2002</risdate><volume>14</volume><issue>11</issue><spage>20</spage><pages>20-</pages><issn>1534-3618</issn><abstract>The Senate passed the Greater Access to Affordable Pharmaceuticals Act (section 812) on July 31, 2002, approving amendments to patent laws to make generic drug options more available to US consumers. Currently manufacturers of brand name drugs are allowed to receive an automatic 30-month stay of generic drug approval while litigation concerning infringement of the patent is pending. The Greater Access to Affordable Pharmaceuticals Act would limit such extensions, allowing drug manufacturers just one 30-month stay.</abstract><cop>Clifton</cop><pub>Aspen Publishers, Inc</pub><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1534-3618 |
| ispartof | Intellectual property & technology law journal, 2002-11, Vol.14 (11), p.20 |
| issn | 1534-3618 |
| language | eng |
| recordid | cdi_proquest_journals_227156226 |
| source | Business Source Complete |
| subjects | Drugs FDA approval Federal legislation Generic drugs Intellectual property Interpretation and construction Litigation Patent law Pharmaceutical industry Prescription drug plans |
| title | Senate passes bill amending drug patent laws |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T08%3A05%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Senate%20passes%20bill%20amending%20drug%20patent%20laws&rft.jtitle=Intellectual%20property%20&%20technology%20law%20journal&rft.au=Tantono,%20Welly&rft.date=2002-11-01&rft.volume=14&rft.issue=11&rft.spage=20&rft.pages=20-&rft.issn=1534-3618&rft_id=info:doi/&rft_dat=%3Cgale_proqu%3EA94820030%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=227156226&rft_id=info:pmid/&rft_galeid=A94820030&rfr_iscdi=true |